{"name":"Cancer Trials Ireland","slug":"cancer-trials-ireland","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Abiraterone acetate, Prednisolone","genericName":"Abiraterone acetate, Prednisolone","slug":"abiraterone-acetate-prednisolone","indication":"Castration-resistant prostate cancer (metastatic or non-metastatic)","status":"phase_2"},{"name":"Cisplatin / Oxaliplatin","genericName":"Cisplatin / Oxaliplatin","slug":"cisplatin-oxaliplatin","indication":"Colorectal cancer (oxaliplatin component)","status":"phase_3"},{"name":"Dexamethasone (IV)","genericName":"Dexamethasone (IV)","slug":"dexamethasone-iv","indication":"Adjunctive treatment in cancer therapy to manage inflammation and treatment-related adverse effects","status":"marketed"}]}],"pipeline":[{"name":"Abiraterone acetate, Prednisolone","genericName":"Abiraterone acetate, Prednisolone","slug":"abiraterone-acetate-prednisolone","phase":"phase_2","mechanism":"Abiraterone acetate inhibits CYP17A1 to block androgen synthesis, while prednisolone suppresses adrenocorticotropic hormone feedback to further reduce testosterone production in castration-resistant prostate cancer.","indications":["Castration-resistant prostate cancer (metastatic or non-metastatic)","Metastatic castration-sensitive prostate cancer (in combination with androgen deprivation therapy)"],"catalyst":""},{"name":"Cisplatin / Oxaliplatin","genericName":"Cisplatin / Oxaliplatin","slug":"cisplatin-oxaliplatin","phase":"phase_3","mechanism":"Cisplatin and oxaliplatin are platinum-based chemotherapy agents that bind to DNA and form cross-links, preventing DNA replication and triggering cancer cell death.","indications":["Colorectal cancer (oxaliplatin component)","Ovarian cancer (cisplatin component)","Testicular cancer (cisplatin component)","Gastric cancer (oxaliplatin component)"],"catalyst":""},{"name":"Dexamethasone (IV)","genericName":"Dexamethasone (IV)","slug":"dexamethasone-iv","phase":"marketed","mechanism":"Dexamethasone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors in the cytoplasm.","indications":["Adjunctive treatment in cancer therapy to manage inflammation and treatment-related adverse effects","Cerebral edema associated with brain tumors","Chemotherapy-induced nausea and vomiting (CINV)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE5EQmxPbEFtZXNxdHhCZWpqWWlIT0pXWVVtRHlLMkltMEtTRGtwRlBNNElJUzFfNFNJcVUwT0xIWU9aU29rNnlIZEdscmJFUm1Ca0E0ajd6RTB5MmkyLVlRZjJTUEFrZHhVUDRMZnJ5SnBzcjktenc?oc=5","date":"2025-12-08","type":"trial","source":"Irish Examiner","summary":"J&J to join Poolbeg on key cancer drug trial - Irish Examiner","headline":"J&J to join Poolbeg on key cancer drug trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOcGVWZkxrVlA4N3M4eTFQQXFqdThMYlVYRGtDa3gwZ3RlbXBOX3dOelZJSnh4WVRvWXRHZF9mZVB2a2lHNUZYY3M2R09NWXpoUEJ5czc0UWsxSmFaT3pLYXdVZnoyRlR2N0tYX2dCVXVaWUMwbXZ2LW8ySUtLNElweXJpSHZ2Si1nZlhpUzNXN0xwVDFPdnlSYXVpYXl5V2J0SERRNGFObTlTVlhLMWxSdUhLdw?oc=5","date":"2025-12-07","type":"trial","source":"The Irish Independent","summary":"J&J to supply drug for Poolbeg Pharma cancer patient trial - The Irish Independent","headline":"J&J to supply drug for Poolbeg Pharma cancer patient trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9oT3BBQ3Ewcm1qcVpBd2hiSFA4WEtSYXZ6Y094amgtUGFsLW1HN2ZaVGVrUGxRekpEZlhuTXFQMmxoMjNSMFJVYkRwdXpHaXlwelQ0OExTcmFYUGpqa0h2VFpXMlpFdHRfUG9j?oc=5","date":"2025-12-03","type":"pipeline","source":"Labiotech.eu","summary":"Five Irish biotechs every industry leader should know about - Labiotech.eu","headline":"Five Irish biotechs every industry leader should know about","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOVUl2U01Fa0Y1WlBva1liR1lXMFRVdmdsZFlrZ3hzdU5UdlcyRTdCUTFNSVJMSHlDVnQxbm9PdlNnSW9rWjB4Vko0QmM3TTlYcXozWmZaVkZaYjlUajNKRUo3ZHhrUWxpcWZSR1gySDItaG40Wkc1eUxjaEJZOUhDek55TEw2WkhnV2NwWGJyVEZvVVNUMGh6T2FVVVdFQQ?oc=5","date":"2025-12-02","type":"trial","source":"The Association of the British Pharmaceutical Industry | ABPI","summary":"UK industry clinical trials: Translating actions into impact - The Association of the British Pharmaceutical Industry | ABPI","headline":"UK industry clinical trials: Translating actions into impact - The Association of the British Pharmaceutical Industry | ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQdmpnWFRUS0E2WTJYX0FwbmZmOFh4VXI5ZnVSNUdSZ3ltNU9VVVo1Zy1iMlMwNE9MUHB0RlJyNHhPV1RkSzFlMm5YR3J5bTZxcEdZMWNlVzl5MUIzQUplYXhwRnhBOFFYRVg2ZE1lSS02RnJ4QlBpXzViVVU4d1hRQjBQdTEwR0hMX1pvN0pGRFFnWTJnSV9j?oc=5","date":"2025-11-01","type":"pipeline","source":"The Times","summary":"The lifesaving drugs made in Ireland — that Irish patients can’t take - The Times","headline":"The lifesaving drugs made in Ireland — that Irish patients can’t take","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOTWVMcGExY0VMc1hFUzVHbDBHcDdsS0sxX20zUG9ZaEZJU20wSHFQY080V3hlMXEzalI0aGk1V3kxaXpMTG1xMkFOSzFzWHk4SkEwRV9EejItVDFROWd2LXJGQmZsZkZkZGxEUkpLbW1jS3ZCSnhNTHZJaVJOQTBSU0Z3R2NkWHV4Vm5LX3M1ZlFjRjQzSEFFMmRBM0NoQQ?oc=5","date":"2025-10-10","type":"trial","source":"PMLiVE","summary":"Ireland’s largest cancer research initiative launches second phase - PMLiVE","headline":"Ireland’s largest cancer research initiative launches second phase","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNRkZTVkoxRGgyXzhNN3hpdTBTcnpWcEJGRjlqUmVnMXNGZmJWX1hTR0Q4VnRoelVLZXV2d3ZxX0IyM0tBaGQtWGhkc016cE03Zk1WaVhwTVBnY2JxUFppdmktdzNBaHBkS2hJTDNEd245WVpQajhfVzlzM24zc2hLTnZiRHA3TkhrMmFuVl82Wk5Jb3U2SHpteXc1N1RUclFaMzFMYzFXNnprOTQ?oc=5","date":"2025-09-26","type":"pipeline","source":"Irish Medical Times","summary":"How a wealthy Ireland fell behind on cancer treatment access - Irish Medical Times","headline":"How a wealthy Ireland fell behind on cancer treatment access","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQb2h2dm5zcFFZTV9KQ3ctRnlOdW5TWUxNVjFnSU54Q29iOXBzYmxPcnQzaXh2SWpYQmczZ3pzS2F5VENVWXRHSnJRUGljSHpseEI4dEZtMk9SUFJCaU0yRjlkQUlZMF9pRkZ0NXl5Q1RYUEtna3ljQ1VSUldhWWlwMg?oc=5","date":"2025-08-14","type":"pipeline","source":"The New York Times","summary":"Tariffs Set to Hit Ireland, Where U.S. Drugmakers Play Tax Games - The New York Times","headline":"Tariffs Set to Hit Ireland, Where U.S. Drugmakers Play Tax Games","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPYThoaTBaQTZGYWpxRWJFdGRIM19lemg3aV9SQzI5YlAwS0pObzFpWi1tQURBUDZyeGpvRlVrNkRicGN0U2lXbzJkNENBWi1JMWRoYUt3RllxNzg3M204SVM5akUwbTk2NmdvVWc5RDlQUUstQ08zcUs4SnVIc3ZpRXoydU1uRURCTzlqZzlOX1p4VDgteThUOW4wU1IzQXZORlIwbExjN05uY3c?oc=5","date":"2025-07-11","type":"trial","source":"Silicon Republic","summary":"Medtech veteran aims to boost Irish clinical trials with new pilot - Silicon Republic","headline":"Medtech veteran aims to boost Irish clinical trials with new pilot","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOMDdkQUFZTm5JOFRQbjFlcHczYWdZb0o3X2R3T0FKbnJpNXVrTmhqWDd5ZFA0VlRjOXN3VzR1NVdBYkxWbTR0Slpva0hYb0t5WTNyVVdsanpqNHVGQVRFMnU4QktteTd5djZDdWtKeDh3cVJJM2lJM3RTT25CZ29sZXJGNmlvcHZrS2swMmx0b1N1MFBYbnlqX1pB?oc=5","date":"2025-05-21","type":"trial","source":"Irish Medical Times","summary":"Rise in pharma-sponsored trials seen here last year – report - Irish Medical Times","headline":"Rise in pharma-sponsored trials seen here last year – report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOWVZocVJEV1BlbmVPQ215V1RWUlJKbkdZT1dtN1B3b3dvMUF1WnhRWmJrb3liOENsdXg5WEs4T2hJdkRlTHM4M2ZzRnB1aHNJVXgtQXlXZHhETW01d2NFVXhpWEVkYzlUUWlERUNTVXRHZlYwdDNLZmFoRUxrQXBiWlFRaVNsNzRFdkpNYVNuZ0c1WkxJTkpUcmdlcGJLTVRIbF9wZXNkdXpwem5rR0UxZmpEcy1jd1NzcF9hUHpCYS0?oc=5","date":"2024-11-20","type":"regulatory","source":"Jazz Pharmaceuticals","summary":"Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Can","headline":"Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previou","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNQmFINnhLNlRwWnowZmRXZjF2eG5JUXhzeU01ZEtRcTRubjB6RmxnQ0hZcnpuN1RvRURRSXV6V2VYR3g5Sk9NSTBaNklSX2dGQzNreUtNdUpqeW9IQkVLc1JiWkRyaW5xX1BnN0J0dUtGWklYX3ZFZ2VVWGVCczhvMW5acVpmaVBteVFCZDV5eFVzeDR1c0IyYWYyaWJyUXZ6MFV2WjdR?oc=5","date":"2022-06-07","type":"trial","source":"Nestlé UK","summary":"Cancer Trials Ireland Becomes Nestlé Ireland Staff Charity - Nestlé UK","headline":"Cancer Trials Ireland Becomes Nestlé Ireland Staff Charity - Nestlé UK","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":1,"phase_3":1,"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}